Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

MK 826

Known as: MK-826 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2012
2012
Abstractβ-Lactam antibiotics represent the most commonly prescribed antibacterial agents. New β-lactams have been introduced… Expand
  • figure 1
  • table I
Review
2002
Review
2002
  • B. Cunha
  • Drugs of today
  • 2002
  • Corpus ID: 10601017
Ertapenem sodium (trade name Invanz, also designated as MK-0826, MK-826 and L-749345), manufactured by Merck & Co., Inc. is a… Expand
Review
2001
Review
2001
Beta-lactam antibiotics represent the most commonly prescribed antibacterial agents. New beta-lactams have been introduced… Expand
2001
2001
Publisher Summary This chapter examines the various developments in antibacterial research. Significant effort continues to be… Expand
Review
2000
Review
2000
During the last few decades, several carbapenems have been developed. The major characteristic of the newer drugs, such as MK-826… Expand
2000
2000
ABSTRACT The activity of MK-826 was compared to the activities of cefoxitin, ceftriaxone, imipenem, and meropenem against 363… Expand
1999
1999
After intravenous administration of MK-826, a new carbapenem antibiotic, the compound exhibited nonlinear pharmacokinetics in… Expand
Highly Cited
1998
Highly Cited
1998
ABSTRACT MK-826 (formerly L-749,345), is a potent 1-β-methyl carbapenem with a long half-life and broad spectrum of activity… Expand
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • table 2